President Trump to Announce Nationwide Medicaid Drug Pricing Model
President Donald Trump is set to announce that all 50 states will participate in a Medicaid drug pricing model aimed at lowering the net price of selected drugs by aligning them with prices paid in certain other countries.
Tyler Longview, TX, September 18, 2026 —
President Donald Trump is preparing to announce a new Medicaid drug pricing model that will include participation from all 50 states. The initiative is designed to reduce the net cost of specific prescription drugs.
The proposed model aims to achieve lower drug prices by pegging them to rates paid in several other countries. Details regarding the specific selection criteria for drugs included in the model and the precise methodology for international price alignment were not immediately available.
The announcement indicates a significant push to reform how prescription medications are priced within the Medicaid program, affecting all U.S. states. The specifics of the implementation timeline and the expected impact on pharmaceutical costs are anticipated to be part of the forthcoming announcement.
Story summarized from the original created by FATIMA HUSSEIN, Associated Press on www.ketk.com, see more information here.
Media gallery
